Consumer advocates are pressing the Biden administration not to privatize a pan-coronavirus vaccine being developed by the U.S. Army if it’s approved. Instead, the government should grant licenses to qualified manufacturers to produce the drug and build government manufacturing facilities, they say. In a July 26 letter to President Joe Biden, 29 consumer and patient organizations say the government must avoid earlier mistakes in managing publicly funded vaccine technology by ensuring this new vaccine, which is being developed in the...